For U.S. residents only. Non-U.S. residents Novartis Pharma US
Learn About Novartis
   
Learn About Clinical Trials
                                   
Non-U.S. Residents
Home
About Kidney Cancer
Study Participation
What is RAD001?
Do You Qualify?
Mailing List
Clinical Trial FAQs
Clinical Trial Terms
About Informed Consent
Non-U.S. Residents
How to use this System


Novartis Oncology is conducting a clinical research study to evaluate the safety and efficacy of the investigational drug RAD001 for participants 18 years of age and older with kidney cancer.

Participation in this study is ongoing in many countries including:

    • Belgium
    • Brazil
    • Czech Republic
    • Egypt
    • France
    • Germany
    • Hong Kong
    • Hungary
    • Italy
    • Korea, Republic of
    • Netherlands
    • Russia
    • Singapore
    • Slovakia (Slovak Republic)
    • South Africa
    • Spain
    • Switzerland
    • Taiwan
    • Thailand
    • Turkey
    • United Kingdom

If you are not a US resident, please visit the ClinicalTrials.gov website for information.

 

Novartis Pharma US